Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

158.86
+2.621.68%
Post-market: 160.001.14+0.72%19:41 EDT
Volume:1.18M
Turnover:187.89M
Market Cap:303.10B
PE:24.02
High:159.72
Open:156.17
Low:156.10
Close:156.24
52wk High:170.46
52wk Low:121.57
Shares:1.91B
Float Shares:1.85B
Volume Ratio:0.73
T/O Rate:0.06%
Dividend:4.67
Dividend Rate:2.94%
EPS(TTM):6.61
EPS(LYR):7.15
ROE:30.35%
ROA:10.25%
PB:7.30
PE(LYR):22.22

Loading ...

Novartis Ag : Argus Research Raises to Buy From Hold

THOMSON REUTERS
·
Mar 11

Novartis upgraded to Buy from Hold at Argus

TIPRANKS
·
Mar 11

Market Outlook: Costco, Novartis and Devon among stock picks

Bloomberg
·
Mar 11

Novartis price target raised to CHF 110 from CHF 92 at Berenberg

TIPRANKS
·
Mar 10

Novartis (NVS) Receives a Hold from Berenberg Bank

TIPRANKS
·
Mar 09

These 8 drugs could help fight dementia - and they're already on the market

Dow Jones
·
Mar 07

BRIEF-Novo And Hims End Feud, Will Sell Obesity Drugs Together- Bloomberg News

Reuters
·
Mar 07

Novartis Shareholders Approve Dividend Raise, Share Capital Reduction

MT Newswires Live
·
Mar 06

Novartis shareholders approve all resolutions proposed by Board of Directors

TIPRANKS
·
Mar 06

Berenberg Raises Price Target on Novartis to $141 From $116, Keeps Hold Rating

MT Newswires Live
·
Mar 06

Second HeLa Lawsuit Resolved As Novartis Reaches Confidential Settlement

Benzinga_recent_news
·
Mar 01

Tariffs Influenced Novartis to Build Over 7 Plants in US, Trump Says

MT Newswires Live
·
Feb 28

Trump says ‘tariffs have influenced’ Novartis to build 7+ facilities

TIPRANKS
·
Feb 28

Atrium Therapeutics Begins Operations With 2 Precision Cardiology Candidates

MT Newswires Live
·
Feb 27

Novartis completes acquisition of Avidity Biosciences

TIPRANKS
·
Feb 27

Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy

GlobeNewswire
·
Feb 27

Novartis Says EMA Panel Recommends Remibrutinib for Chronic Spontaneous Urticaria

MT Newswires Live
·
Feb 27

Novartis receives positive CHMP opinion for remibrutinib in CSU

TIPRANKS
·
Feb 27

Novartis to build radioligand therapy site in Denton, Texas

TIPRANKS
·
Feb 25

COLUMN-Novartis quietly settles Henrietta Lacks suit as family’s legal push gains steam

Reuters
·
Feb 24